The medical device and pharmaceutical industries each share in a mission to improve health outcomes, from prevention to intervention. As a result of this shared mission, integration and overlap between these two industries has been taking place for decades.
Over the course of this white paper, the different categories of combination products within the EU will be described along with the regulatory pathways designed to ensure they are safe and perform as intended.
